Details of the Drug Formulations

General Information of Drug (ID: DMSYFM8)

Drug Name
Cysteamine Drug Info
Synonyms
Becaptan; Cisteamina; Cystavision; Cysteamide; Cysteamin; Cysteinamine; Decarboxycysteine; Ethanethiolamine; Lambraten; Lambratene; MEA; Mecramine; Mercamin; Mercamine; Mercaptamin; Mercaptamina; Mercaptamine; Mercaptaminum; Mercaptoethylamine; Merkamin; Riacon; Thioethanolamine; Aminoethyl mercaptan; Cisteamina [Italian]; Cysteamine bitartate; L 1573; WR 347; Beta-Aminoethanethiol; Beta-Aminoethylthiol; Beta-MEA; Beta-Mercaptoethylamine; C-9500; Cysteamine (USAN); Cysteamine [USAN:BAN]; L-1573; MEA (mercaptan); Mercaptamina [INN-Spanish]; Mercaptamine (INN); Mercaptaminum [INN-Latin]; (2-Mercaptoethyl)amine; (Mercaptoethyl)ammonium toluene-p-sulphonate; 1-Amino-2-mercaptoethylamine; 2-AMINO-ETHANETHIOL; 2-Amino-1-ethanethiol; 2-Aminoethanethiol; 2-Aminoethyl mercaptan; 2-Mercaptoethanamine; 2-Mercaptoethylamine; 2-Mercaptoethylamine, polymer-bound; 641022_ALDRICH
Indication
Disease Entry ICD 11 Status REF
Nephropathic cystinosis 5C60 Approved [1]
Therapeutic Class
Nephropathic cystinosis therapy
Cross-matching ID
PubChem CID
6058
ChEBI ID
CHEBI:17141
CAS Number
60-23-1
TTD ID
D0V0LB
VARIDT ID
DR00873
INTEDE ID
DR0397
ACDINA ID
D00161

Full List of Drug Formulations Containing This Drug

Cysteamine 150 mg capsule
Company Formulation ID FDA Description
Mylan Pharamceuticals F05197 Sodium lauryl sulfate; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Gelatin, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Cysteamine 50 mg capsule
Company Formulation ID FDA Description
Mylan Pharamceuticals F05199 Sodium lauryl sulfate; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Gelatin, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Cysteamine 25 mg capsule
Company Formulation ID FDA Description
Raptor Therapeutics F05198 Sodium lauryl sulfate; Fd&c blue no. 2; Talc; Titanium dioxide; Triethyl citrate; Water; Cellulose, microcrystalline; Gelatin; Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a
------------------------------------------------------------------------------------
Cysteamine 75 mg capsule
Company Formulation ID FDA Description
Raptor Therapeutics F05200 Sodium lauryl sulfate; Fd&c blue no. 2; Talc; Titanium dioxide; Triethyl citrate; Water; Cellulose, microcrystalline; Gelatin; Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a
------------------------------------------------------------------------------------
Cysteamine Bitartrate eq 50mg base capsule
Company Formulation ID FDA Description
Mylan Pharmaceuticals F23414 Ammonium Hydroxide; Black Iron Oxide; Colloidal Silicon Dioxide; Croscarmellose Sodium; Gelatin; Magnesium Stearate; Microcrystalline Cellulose; Pharmaceutical Glaze; Pregelatinized Starch; Propylene Glycol; Sodium Lauryl Sulfate; Titanium Dioxide
------------------------------------------------------------------------------------
Cysteamine Bitartrate eq 75mg base capsule
Company Formulation ID FDA Description
Horizon Therapeutics Usa F23415 Gelatin; Ink (Blue And White); Titanium Dioxide
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015